IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,064 | -9.5% | 110,532 | 0.0% | 0.05% | +27.8% |
| Q2 2023 | $1,176 | +1.1% | 110,532 | 0.0% | 0.04% | -47.8% |
| Q1 2023 | $1,163 | -15.0% | 110,532 | 0.0% | 0.07% | -9.2% |
| Q4 2022 | $1,369 | -99.9% | 110,532 | 0.0% | 0.08% | +55.1% |
| Q3 2022 | $1,145,000 | -10.1% | 110,532 | 0.0% | 0.05% | -27.9% |
| Q2 2022 | $1,274,000 | -8.3% | 110,532 | 0.0% | 0.07% | +17.2% |
| Q1 2022 | $1,390,000 | +7.8% | 110,532 | 0.0% | 0.06% | +65.7% |
| Q4 2021 | $1,289,000 | -10.7% | 110,532 | 0.0% | 0.04% | +9.4% |
| Q3 2021 | $1,444,000 | +1.5% | 110,532 | 0.0% | 0.03% | +10.3% |
| Q2 2021 | $1,423,000 | +15.1% | 110,532 | 0.0% | 0.03% | +31.8% |
| Q1 2021 | $1,236,000 | -1.7% | 110,532 | 0.0% | 0.02% | -18.5% |
| Q4 2020 | $1,258,000 | +26.6% | 110,532 | 0.0% | 0.03% | +12.5% |
| Q3 2020 | $994,000 | -12.9% | 110,532 | 0.0% | 0.02% | -25.0% |
| Q2 2020 | $1,141,000 | +2.3% | 110,532 | 0.0% | 0.03% | -31.9% |
| Q1 2020 | $1,115,000 | -24.2% | 110,532 | 0.0% | 0.05% | -17.5% |
| Q4 2019 | $1,471,000 | +55.0% | 110,532 | 0.0% | 0.06% | +50.0% |
| Q3 2019 | $949,000 | -21.5% | 110,532 | 0.0% | 0.04% | -22.4% |
| Q2 2019 | $1,209,000 | -3.4% | 110,532 | 0.0% | 0.05% | -3.9% |
| Q1 2019 | $1,252,000 | +9.3% | 110,532 | 0.0% | 0.05% | +21.4% |
| Q4 2018 | $1,145,000 | -43.9% | 110,532 | 0.0% | 0.04% | -20.8% |
| Q3 2018 | $2,040,000 | -50.8% | 110,532 | -49.0% | 0.05% | -39.8% |
| Q2 2018 | $4,147,000 | +23.9% | 216,879 | 0.0% | 0.09% | +109.5% |
| Q1 2018 | $3,346,000 | -56.8% | 216,879 | -58.0% | 0.04% | -64.1% |
| Q4 2017 | $7,748,000 | -39.9% | 516,879 | -36.7% | 0.12% | -47.3% |
| Q3 2017 | $12,882,000 | +10.6% | 816,879 | +32.4% | 0.22% | +9.4% |
| Q2 2017 | $11,647,000 | -4.8% | 616,879 | -13.9% | 0.20% | -25.1% |
| Q1 2017 | $12,230,000 | +54.8% | 716,879 | +38.7% | 0.27% | +54.9% |
| Q4 2016 | $7,903,000 | +129.5% | 516,879 | +138.3% | 0.18% | +157.4% |
| Q3 2016 | $3,444,000 | +21.4% | 216,879 | 0.0% | 0.07% | +15.3% |
| Q2 2016 | $2,836,000 | +19.5% | 216,879 | 0.0% | 0.06% | +28.3% |
| Q1 2016 | $2,373,000 | -5.6% | 216,879 | 0.0% | 0.05% | -2.1% |
| Q4 2015 | $2,514,000 | +11.2% | 216,879 | 0.0% | 0.05% | -6.0% |
| Q3 2015 | $2,260,000 | -13.6% | 216,879 | 0.0% | 0.05% | -55.8% |
| Q2 2015 | $2,616,000 | -24.6% | 216,879 | 0.0% | 0.11% | -29.4% |
| Q1 2015 | $3,470,000 | +4.4% | 216,879 | 0.0% | 0.16% | +36.8% |
| Q4 2014 | $3,323,000 | +18.3% | 216,879 | 0.0% | 0.12% | +13.6% |
| Q3 2014 | $2,810,000 | -15.5% | 216,879 | 0.0% | 0.10% | -23.1% |
| Q2 2014 | $3,325,000 | +24.4% | 216,879 | 0.0% | 0.13% | +38.1% |
| Q1 2014 | $2,672,000 | +6.1% | 216,879 | 0.0% | 0.10% | +7.8% |
| Q4 2013 | $2,518,000 | -1.9% | 216,879 | 0.0% | 0.09% | +7.1% |
| Q3 2013 | $2,568,000 | +19.2% | 216,879 | 0.0% | 0.08% | +23.5% |
| Q2 2013 | $2,154,000 | – | 216,879 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |